0000896262-23-000023.txt : 20230227
0000896262-23-000023.hdr.sgml : 20230227
20230227212034
ACCESSION NUMBER: 0000896262-23-000023
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230223
FILED AS OF DATE: 20230227
DATE AS OF CHANGE: 20230227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Muscato Nick
CENTRAL INDEX KEY: 0001923993
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24260
FILM NUMBER: 23678016
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMEDISYS INC
CENTRAL INDEX KEY: 0000896262
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082]
IRS NUMBER: 113131700
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
BUSINESS PHONE: 2252922031
MAIL ADDRESS:
STREET 1: 3854 AMERICAN WAY
STREET 2: SUITE A
CITY: BATON ROUGE
STATE: LA
ZIP: 70816
FORMER COMPANY:
FORMER CONFORMED NAME: ANALYTICAL NURSING MANAGEMENT CORP
DATE OF NAME CHANGE: 19940819
FORMER COMPANY:
FORMER CONFORMED NAME: M&N CAPITAL CORP
DATE OF NAME CHANGE: 19930125
4
1
wf-form4_167755081280486.xml
FORM 4
X0306
4
2023-02-23
0
0000896262
AMEDISYS INC
AMED
0001923993
Muscato Nick
3854 AMERICAN WAY
SUITE A
BATON ROUGE
LA
70816
0
1
0
0
Chief Strategy Officer
Common Stock
2023-02-23
4
A
0
1363
0
A
15495
D
Common Stock
213
I
By 401(k) Plan
Stock Option (Right to Buy)
91.77
2023-02-23
4
A
0
2876
0
A
2033-02-23
Common Stock
2876.0
2876
D
Restricted Stock Unit (Performance-Based Vesting)
2023-02-23
4
A
0
2725
0
A
Common Stock
2725.0
2725
D
The Issuer awarded the Reporting Person 1,363 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 1/3 installments on each of February 20, 2024, 2025 and 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date.
The information in this report is based on a plan statement dated as of December 31, 2022.
The Stock Options are subject to time-based vesting conditions and will vest in equal, 1/3 installments on each of February 20, 2024, 2025 and 2026, provided that the Reporting Person remains continuously employed by the Issuer on each such date.
The performance-based RSUs will cliff vest following a three-year performance period ending December 31, 2025 based on the Company's achievement of a pre-established performance measure for 2023, as modified by the Company's three-year total shareholder return percentile rank compared to a pre-established comparator group. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0% to 200% of the amount reported depending on the level of performance achieved.
Jennifer Guckert Griffin, pursuant to a power of attorney
2023-02-27